204
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Uncommon Haemorrhagic Cystitis of Infectious Origin: A Narrative Review for Urologists

, ORCID Icon, , , , ORCID Icon, , , , ORCID Icon, & show all
Pages 365-373 | Received 13 Mar 2023, Accepted 20 Jul 2023, Published online: 04 Aug 2023

References

  • Laguna MP, Albers P, Algaba F. EAU guidelines. Edn. Presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5; 2022.
  • Haldar S, Dru C, Bhowmick NA. Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2014;2(3):199–208.
  • Mantica G, Ambrosini F, Riccardi N, et al. Genitourinary tuberculosis: a comprehensive review of a neglected manifestation in low-endemic countries. Antibiot Basel Switz. 2021;10(11):1399.
  • Furukawa R, Homma H, Inoue T, Horiuchi H, Usui K. Cytomegalovirus hemorrhagic cystitis in a malignant glioma patient treated with temozolomide. Intern Med Tokyo Jpn. 2018;57(20):3047–3050. doi:10.2169/internalmedicine.1005-18
  • Visintini E, Visintini C, Venturini M, Palese A. Patients’ experience of haemorrhagic cystitis after Haematopoietic Stem Cell Transplantation: findings from a phenomenological study. Eur J Oncol Nurs. 2021;51:101926. doi:10.1016/j.ejon.2021.101926
  • Mori Y, Miyamoto T, Kato K, et al. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18(3):458–465. doi:10.1016/j.bbmt.2011.07.025
  • Ismail M, Hashim H. Complications of fungal cystitis. Curr Bladder Dysfunct Rep. 2013;8(3):212–216. doi:10.1007/s11884-013-0191-x
  • Odabasi Z, Mert A. Candida urinary tract infections in adults. World J Urol. 2020;38(11):2699–2707. doi:10.1007/s00345-019-02991-5
  • Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am. 2014;28(1):61–74. doi:10.1016/j.idc.2013.09.004
  • World Health Organization (WHO). Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
  • Colodner R, Nuri Y, Chazan B, Raz R. Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. Eur J Clin Microbiol Infect Dis. 2008;27(4):301–305. doi:10.1007/s10096-007-0438-6
  • Álvarez-Lerma F, Nolla-Salas J, León C, et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med. 2003;29(7):1069–1076. doi:10.1007/s00134-003-1807-y
  • Goetz LL, Howard M, Cipher D, Revankar SG. Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord. 2010;48(1):51–54. doi:10.1038/sc.2009.81
  • Delgado J, Calvo N, Gomis A, et al. Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication. Transplant Proc. 2010;42(8):2944–2946. doi:10.1016/j.transproceed.2010.08.019
  • Safdar N, Slattery WR, Knasinski V, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis. 2005;40(10):1413–1421. doi:10.1086/429620
  • Esmailzadeh A, Zarrinfar H, Fata A, Sen T. High prevalence of candiduria due to non- albicans Candida species among diabetic patients: a matter of concern? J Clin Lab Anal. 2018;32(4):e22343. doi:10.1002/jcla.22343
  • Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis. 2000;30(1):14–18. doi:10.1086/313583
  • Padawer D, Pastukh N, Nitzan O, et al. Catheter-associated candiduria: risk factors, medical interventions, and antifungal susceptibility. Am J Infect Control. 2015;43(7):e19–e22. doi:10.1016/j.ajic.2015.03.013
  • Duong DT, Goodman HS. Eosinophilic cystitis caused by Candida glabrata: a case report. Urol Case Rep. 2019;26:100970. doi:10.1016/j.eucr.2019.100970
  • Greene MH. Emphysematous cystitis due toClostridium perfringens and Candida albicans in Two patients with hematologic malignant conditions. Cancer. 1992;70(11):2658–2663. doi:10.1002/1097-0142(19921201)70:11<2658::AID-CNCR2820701115>3.0.CO;2-B
  • Tran L, Thomas M, Harvey J, Sampath R, Rose R. 1700. A rare case of candida glabrata hemorrhagic cystitis with empagliflozin use. Open Forum Infect Dis. 2019;6(Supplement_2):S622–S623. doi:10.1093/ofid/ofz360.1564
  • Levine MJ. Empagliflozin for type 2 diabetes mellitus: an overview of Phase 3 clinical trials. Curr Diabetes Rev. 2017;13(4). doi: 10.2174/1573399812666160613113556
  • Khokhar F, Hernandez C, Mahapatra R. Fournier’s gangrene in an HIV-positive patient on empagliflozin for the treatment of diabetes mellitus. Cureus. 2022. doi:10.7759/cureus.26083
  • Kim G, Gerich JE, Salsali A, et al. Empagliflozin (EMPA) increases genital infections but not urinary tract infections (UTIs) in pooled data from four pivotal Phase III trials. Diabetes. 2013;62(Suppl 1):LB21 (Abstract 74–LB).
  • Thomas L, Tracy CR. Treatment of fungal urinary tract infection. Urol Clin North Am. 2015;42(4):473–483. doi:10.1016/j.ucl.2015.05.010
  • D’Amico MJ, Foss H, Uhr A, Rudnick B, Kloniecke E, Gomella LG. Hemorrhagic cystitis: a review of the literature and treatment options. Can J Urol. 2022;29(5):11276–11283.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–e50.
  • Muthe MM, Shirsath SD, Shirsath RD, Firke VP. A rare case of isolated vesical mucormycosis in a patient with COVID-19 pneumonitis. Indian J Radiol Imaging. 2022;32(03):408–410. doi:10.1055/s-0042-1744137
  • Manikandan R, Kumar S, Dorairajan LN. Hemorrhagic cystitis: a challenge to the urologist. Indian J Urol. 2010;26(2):159–166. doi:10.4103/0970-1591.65380
  • Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405–e421. doi:10.1016/S1473-3099(19)30312-3
  • Lanternier F, Sun HY, Ribaud P, Singh N, Kontoyiannis DP, Lortholary O. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis. 2012;54(11):1–8. doi:10.1093/cid/cis195
  • Bader MS, Hawboldt J, Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2010;122(6):7–15. doi:10.3810/pgm.2010.11.2217
  • Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113(1):14–19. doi:10.1016/S0002-9343(02)01055-0
  • Sabih A, Leslie SW. Complicated urinary tract infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: http://www.ncbi.nlm.nih.gov/books/NBK436013/. Accessed July 26, 2023.
  • Teh J, Quinlan M, Bolton D. Salmonella Oranienburg haemorrhagic cystitis in an immunocompetent young male. JMM Case Rep. 2017;4(8):e005105. doi:10.1099/jmmcr.0.005105
  • Na SK, Jung HK, Kim YS, et al. Hemorrhagic cystitis with massive bleeding from nontyphoidal Salmonella infection: a case report. Kidney Res Clin Pract. 2013;32(2):84–86. doi:10.1016/j.krcp.2013.04.005
  • Mehta R, Pathak A. Emerging chryseobacterium indologenes infection in Indian neonatal intensive care units: a case report. Antibiotics. 2018;7(4):109. doi:10.3390/antibiotics7040109
  • Olanipekun T, Effoe V, Turner J, Flood M. Bladder necrosis and perforation in end-stage renal disease and recurrent urinary tract infection: a rare medical emergency. Int J Crit Illn Inj Sci. 2019;9(2):101–104. doi:10.4103/IJCIIS.IJCIIS_72_18
  • Amano M, Shimizu T. Emphysematous cystitis: a review of the literature. Intern Med. 2014;53(2):79–82. doi:10.2169/internalmedicine.53.1121
  • Mokabberi R, Ravakhah K. Emphysematous urinary tract infections: diagnosis, treatment and survival (Case Review Series). Am J Med Sci. 2007;333(2):111–116. doi:10.1097/00000441-200702000-00009
  • Bjurlin MA, Hurley SD, Kim DY, et al. Clinical outcomes of nonoperative management in emphysematous urinary tract infections. Urology. 2012;79(6):1281–1285. doi:10.1016/j.urology.2012.02.023
  • Yoshida K, Murao K, Fukuda N, Tamura Y, Ishida T. Emphysematous cystitis with diabetic neurogenic bladder. Intern Med. 2010;49(17):1879–1883. doi:10.2169/internalmedicine.49.3247
  • Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625–663.
  • van Nieuwkoop C, Hoppe BPC, Bonten TN, et al. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51(11):1266–1272. doi:10.1086/657071
  • Wagenlehner FME, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated Urinary Tract Infections. Dtsch Ärztebl Int. 2011. doi:10.3238/arztebl.2011.0415
  • World Health organization (WHO). Global Tuberculosis Report 2022. Geneva: World Health Organization; 2022. Licence: cc bY-Nc-sa 3.0 iGo.
  • Gow J. Genitourinary tuberculosis. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell’s Urology. 7th ed. Philadelphia, PA: WB Saunders Company; 1998:807–836.
  • Kulchavenya E. Extrapulmonary tuberculosis: are statistical reports accurate? Ther Adv Infect Dis. 2014;2(2):61–70. doi:10.1177/2049936114528173
  • Figueiredo AA, Lucon AM, Srougi M, Schlossberg D. Urogenital tuberculosis. Microbiol Spectr. 2017;5(1). doi:10.1128/microbiolspec.TNMI7-0015-2016
  • Muneer A, Macrae B, Krishnamoorthy S, Zumla A. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019;16(10):573–598. doi:10.1038/s41585-019-0228-9
  • Figueiredo AA, Lucon AM, Gomes CM, Srougi M. Urogenital tuberculosis: patient classification in seven different groups according to clinical and radiological presentation. Int Braz J Urol. 2008;34(4):422–32; discussion 432. doi:10.1590/S1677-55382008000400004
  • Hemal AK, Gupta NP, Rajeev TP, Kumar R, Dar L, Seth P. Polymerase chain reaction in clinically suspected genitourinary tuberculosis: comparison with intravenous urography, bladder biopsy, and urine acid fast bacilli culture. Urology. 2000;56(4):570–574. doi:10.1016/S0090-4295(00)00668-3
  • Moussa OM, Eraky I, El-Far MA, Osman HG, Ghoneim MA. Rapid diagnosis of genitourinary tuberculosis by polymerase chain reaction and non-radioactive DNA hybridization. J Urol. 2000;164(2):584–588. doi:10.1016/S0022-5347(05)67427-7
  • World Health Organization (WHO). The use of next-generation sequencing technologies for the detection of mutations associated with drug; 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/274443/WHO-CDS-TB-2018.19-eng.pdf. Accessed August 3, 2021.
  • World Health Organization (WHO). Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detec-Tion of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pul-Monary and Extrapulmonary TB in Adults and Children: Policy Update. Geneva, Switzerland: World Health Organization; 2013.
  • Chen K, Malik AA, Nantasenamat C, et al. Clinical validation of urine-based Xpert® MTB/RIF assay for the diagnosis of urogenital tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2020;95:15–21.
  • World Health Organization (WHO). The Use of Lateral Flow Urine Lipoarabinomannan Assay (‎LF-LAM)‎ for the Diagnosis and Screening of Active Tuberculosis in People Living with HIV: Policy Guidance. World Health Organization; 2015. Available from: https://apps.who.int/iris/handle/10665/193633. Accessed July 26, 2023.
  • Figueiredo AA, Lucon AM, Arvellos AN, et al. A better understanding of urogenital tuberculosis pathophysiology based on radiological findings. Eur J Radiol. 2010;76(2):246–257. doi:10.1016/j.ejrad.2009.05.049
  • Shapiro AL, Viter VI. Цистоскопия и эндовезикальная биопсия при туберкулезе почек [Cystoscopy and endovesical biopsy in renal tuberculosis]. Urol Nefrol. 1989;1:12–15. Russian.
  • World Health Organization (WHO). Consolidated Guidelines on Tuberculosis. Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
  • Figueiredo AA, Lucon AM, Junior RF, Srougi M. Epidemiology of urogenital tuberculosis worldwide: urogenital tuberculosis epidemiology. Int J Urol. 2008;15(9):827–832. doi:10.1111/j.1442-2042.2008.02099.x
  • de Figueiredo AA, Lucon AM, Srougi M. Bladder augmentation for the treatment of chronic tuberculous cystitis. Clinical and urodynamic evaluation of 25 patients after long term follow-up. Neurourol Urodyn. 2006;25(5):433–440. doi:10.1002/nau.20264
  • Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet Lond Engl. 2014;383(9936):2253–2264. doi:10.1016/S0140-6736(13)61949-2
  • LoVerde PT. Schistosomiasis. Adv Exp Med Biol. 2019;1154:45–70.
  • Riccardi N, Nosenzo F, Peraldo F, et al. Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: neglected no more? PLoS Negl Trop Dis. 2017;11(3):e0005237. doi:10.1371/journal.pntd.0005237
  • Mantica G, Van der Merwe A, Terrone C, et al. Awareness of European practitioners toward uncommon tropical diseases: are we prepared to deal with mass migration? Results of an international survey. World J Urol. 2020;38(7):1773–1786. doi:10.1007/s00345-019-02957-7
  • Chiamah OC, Ubachukwu PO, Anorue CO, Ebi S. Urinary schistosomiasis in Ebonyi State, Nigeria from 2006 to 2017. J Vector Borne Dis. 2019;56(2):87–91. doi:10.4103/0972-9062.263721
  • World Health Organization (WHO). Guideline on Control and Elimination of Human Schistosomiasis. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
  • Comelli A, Riccardi N, Canetti D, et al. Delay in schistosomiasis diagnosis and treatment: a multicenter cohort study in Italy. J Travel Med. 2020;27(1):taz075. doi:10.1093/jtm/taz075
  • Kinkel HF, Dittrich S, Bäumer B, Weitzel T. Evaluation of eight serological tests for diagnosis of imported schistosomiasis. Clin Vaccine Immunol. 2012;19(6):948–953. doi:10.1128/CVI.05680-11
  • Cucchetto G, Buonfrate D, Marchese V, et al. High-dose or multi-day praziquantel for imported schistosomiasis? A systematic review. J Travel Med. 2019;26(7):taz050. doi:10.1093/jtm/taz050
  • Ndamse CC, Masamba P, Kappo AP. Bioorganometallic compounds as novel drug targets against schistosomiasis in Sub-Saharan Africa: an alternative to praziquantel? Adv Pharm Bull. 2022;12(2):283–297. doi:10.34172/apb.2022.029
  • Zwang J, Olliaro PL, Jones MK. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014;8(11):e3286. doi:10.1371/journal.pntd.0003286
  • Molehin AJ, McManus DP, You H. Vaccines for human schistosomiasis: recent progress, new developments and future prospects. Int J Mol Sci. 2022;23(4):2255. doi:10.3390/ijms23042255
  • Rennar GA, Gallinger TL, Mäder P, et al. Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects. Eur J Med Chem. 2022;242:114641. doi:10.1016/j.ejmech.2022.114641